BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
-5.16%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$391M
AUM Growth
+$391M
(-5.9%)
Cap. Flow
+$2.61M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
39.51%
Holding
78
New
4
Increased
33
Reduced
22
Closed
3
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$13.2M |
| 2 |
Medtronic
MDT
|
$2.22M |
| 3 |
Amazon
AMZN
|
$1.66M |
| 4 |
Edwards Lifesciences
EW
|
$1.66M |
| 5 |
NVIDIA
NVDA
|
$1.24M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
$14.9M |
| 2 |
Becton Dickinson
BDX
|
$4.25M |
| 3 |
Unilever
UL
|
$3.56M |
| 4 |
Apple
AAPL
|
$496K |
| 5 |
3M
MMM
|
$450K |
Sector Composition
| 1 | Technology | 24.71% |
| 2 | Healthcare | 22.08% |
| 3 | Industrials | 13.04% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$15.2B
| $5.34M | 1.36% |
15,280
+325
| +2% | +$114K |
|
27
Xylem
XYL
$34B
| $5.31M | 1.36% |
62,309
+691
| +1% | +$58.9K |
|
28
Nike
NKE
$110B
| $4.9M | 1.25% |
36,430
+1,424
| +4% | +$192K |
|
|
29
Edwards Lifesciences
EW
$47.7B
| $4.88M | 1.25% |
41,483
+14,066
| +51% | +$1.66M |
|
30
Chevron
CVX
$318B
| $4.49M | 1.15% |
27,575
+84
| +0.3% | +$13.7K |
|
31
PepsiCo
PEP
$203B
| $4.01M | 1.02% |
23,945
-123
| -0.5% | -$20.6K |
|
32
Novartis
NVS
$248B
| $3.18M | 0.81% |
36,233
-4,867
| -12% | -$427K |
|
33
Exxon Mobil
XOM
$477B
| $2.99M | 0.76% |
36,174
-130
| -0.4% | -$10.7K |
|
34
Church & Dwight Co
CHD
$22.7B
| $2.78M | 0.71% |
27,958
+9,970
| +55% | +$991K |
|
35
AbbVie
ABBV
$374B
| $2.48M | 0.63% |
15,312
-590
| -4% | -$95.6K |
|
36
Aptiv
APTV
$17.3B
| $2.33M | 0.59% |
19,430
+8,768
| +82% | +$1.05M |
|
|
37
Medtronic
MDT
$118B
| $2.22M | 0.57% |
+19,969
| New | +$2.22M |
|
38
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.67M | 0.43% |
30,000
-3,600
| -11% | -$200K |
|
39
Welltower
WELL
$112B
| $1.44M | 0.37% |
15,000
+5,090
| +51% | +$489K |
|
40
Intel
INTC
$105B
| $1.39M | 0.35% |
27,965
-5,990
| -18% | -$297K |
|
41
Ironwood Pharmaceuticals
IRWD
$201M
| $1.21M | 0.31% |
96,000
-6,946
| -7% | -$87.4K |
|
|
42
Becton Dickinson
BDX
$54.3B
| $1.2M | 0.31% |
4,491
-15,965
| -78% | -$4.25M |
|
|
43
3M
MMM
$81B
| $1.07M | 0.27% |
7,195
-3,025
| -30% | -$450K |
|
|
44
Unilever
UL
$158B
| $882K | 0.23% |
19,335
-78,124
| -80% | -$3.56M |
|
45
Bristol-Myers Squibb
BMY
$96.7B
| $854K | 0.22% |
11,700
| – | – |
|
46
Pembina Pipeline
PBA
$21.9B
| $844K | 0.22% |
22,428
| – | – |
|
47
Union Pacific
UNP
$132B
| $763K | 0.19% |
2,794
-15
| -0.5% | -$4.1K |
|
48
Thermo Fisher Scientific
TMO
$183B
| $635K | 0.16% |
1,075
| – | – |
|
49
Trane Technologies
TT
$90.9B
| $606K | 0.15% |
3,970
| – | – |
|
50
Novo Nordisk
NVO
$252B
| $533K | 0.14% |
4,800
-185
| -4% | -$20.5K |
|